-
Innovation Ranking
NewInnovation Ranking – Just Eat Takeaway.com NV
Just Eat Takeawaycom NV (Just Eat), formerly Takeaway.com NV, is a provider of food delivery services. The company's business includes a platform that connects consumers and restaurants. It offers services through various applications and websites such as Lieferando.de, Bistro.sk, Lieferservice.at, Just Eat, Pyszne.pl, Takeaway.com and Thuisbezorgd.nl. Its platforms allow users a wide range of restaurants, to scroll through or search for a particular restaurant or cuisine and place an order. It collaborates with local restaurants and payment banks across cities...
-
Product Insights
NewLikelihood of Approval Analysis for Appetite (Eating) Disorders
Overview How likely is it that the drugs in Appetite (Eating) Disorders will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Appetite (Eating) Disorders Overview Appetite (eating) disorders are psychological conditions that...
-
Product Insights
NewLikelihood of Approval Analysis for Binge Eating Disorder
Overview How likely is it that the drugs in Binge Eating Disorder will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Binge Eating Disorder Overview Binge eating disorder is a serious condition...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TNX-1900 in Binge Eating Disorder
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TNX-1900 in Binge Eating Disorder report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. TNX-1900 in Binge Eating Disorder Drug Details: Oxytocin (TI-001) is under...
-
Product Insights
Appetite (Eating) Disorders – Drugs In Development, 2023
Global Markets Direct’s, ‘Appetite (Eating) Disorders - Drugs In Development, 2023’, provides an overview of the Appetite (Eating) Disorders pipeline landscape. The report provides comprehensive information on the therapeutics under development for Appetite (Eating) Disorders, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Binge Eating Disorder – Drugs In Development, 2023
Global Markets Direct’s, ‘Binge Eating Disorder - Drugs In Development, 2023’, provides an overview of the Binge Eating Disorder pipeline landscape. The report provides comprehensive information on the therapeutics under development for Binge Eating Disorder, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – NOE-115 in Binge Eating Disorder
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - NOE-115 in Binge Eating Disorder report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. NOE-115 in Binge Eating Disorder Drug Details: NOE-115 is under development...
-
Company Insights
Innovation and Patenting activity of Just Eat Takeawaycom NV Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Just Eat Takeawaycom NV Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Psilocybin in Binge Eating Disorder
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Psilocybin in Binge Eating Disorder Drug Details: Psilocybin (TRP-8802) is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ketamine in Binge Eating Disorder
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ketamine in Binge Eating Disorder report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Ketamine in Binge Eating Disorder Drug Details:Ketamine is under development for the...